Specifically, we detected higher levels of GM-CSF in HCs [mean: 8.74 (SEM: 2.08)] than in MS [mean: 7.33 (SEM: 2.40); p = 0.0102], and this was also true when analyzing the levels of IL-1a in the control group [mean: 6.29 (SEM: 1.09)] compared to the patient group [mean: 4.85 (SEM: 0.65); p = 0.0012]. The gene discussed is IL1A; the disease is myeloid sarcoma.